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ABSTRACT 
Microsponge is recent novel technique for control release and target specific drug delivery system. Microsponge technology has been 
introduced in pharmaceutical industry to provide the controlled release of active drug ingredient for the application into the skin in order to 
decrease systemic exposure and reduce local cutaneous reactions to active drugs. Microsponges comprises of microporous beads,  typically 10-
25 microns in diameter, loaded with active agent. The microsponge releases its active ingredient on a time mode, when applied to the skin,  and 
also in response to other stimuli that are used mostly for topical and recently for oral administration. Microsponge technology has many 
favourable characteristics which make It all around suitable as drug delivery vehicle. Microsponge systems can suspend or entrap a wide 
variety of substances, and then be incorporated into a formulated product such as a gel, cream, liquid or powder. The outer surface is mostly 
porous, allowing the sustained flow of substances out of the sphere. Microsponge drug delivery system causes increased efficacy for the 
topically active agents with enhanced safety and product stability for a longer period of time with reduction in side effects. In addition their 
non-allergenic, non-irritating, non-mutagenic and nontoxic behaviour makes them the suitable dosage form. The present review emphasis 
Microsponge drug delivery system along with its release mechanism.  
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INTRODUCTION  
One of the biggest challenges faced by pharmaceutical 
scientists is to control the rate of delivery of the active 
ingredients to a particular organ in the human body. Various 
reliable systems have been investigated for the transdermal 
delivery system using the skin as the entry for the several 
organ. It has improved the safety and efficacy of numerous 
drugs that may be better administered via skin. But 
transdermal delivery system is not provable for delivery of 
materials whose final target is skin itself1. It is a challenging 
area of research for the drugs which are applied on the 
epidermis for their controlled systemic circulation in 
predetermined amounts as well as their localization in the 
target organs. Topical delivery of drugs faces different types 
of problems. Ointments, which are used for aesthetic 
purposes offers various problems such as greasy and sticky 
appearance, thus leads to patient incompliance. There is 
need of high concentrations of active ingredients for such 
type of vehicles in order to achieve effective therapy, 
resulting in irritation and allergic reactions2. The other 
disadvantages of topical formulations include uncontrolled 
rate of evaporation of active agents with unpleasant odour, 
high chances of incompatibility of drugs with the vehicles. 
Thus, there exists the need for system to maximize the 
amount of time that an active agent is present either on skin 
surface or within the epidermis, meanwhile minimizing its 
transdermal penetration into the body. The microsponge 
delivery system fulfills these requirements. Microsponges 
are said to be a porous microspheres which consist of 
numerous of interconnected voids of particle size ranging 
from 5-300 µm. The microsponges are having capacity to 
entrap wide range of pharmaceutical active ingredients such 
as fragrances, essential oils, sunscreens, emollients and anti-
infectives which serve to be a topical drug delivery system. 
Finally the use of the porous microsponges with addition to 
active ingredients can be formulated into various dosage 
forms such as creams, lotions and powders. The non-
collapsible structures are found within the porous surface of 
microsponge through which active ingredients are released 
in controlled manner. The basic approach of the 
microsponge technology lies in the application of 
conventional formulations for releasing the active 
ingredients from prolonged period of time. Cosmetics and 
skin care preparations are made to work only on the 
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epidermal layer of the skin. The common result is over-
medication, which results in the serious side effects3,4. 
Therefore Microsponge is a advance technology for 
delivering the drugs in a well released pattern with 
maximum therapeutic effect.  
Benefits of Microsponge Technology4   
Microsponge technology gives:  
• Increased product performance.   
• Extended release.   
• Improved patient compliance and reduced irritation.  
• Improved product elegancy.   
• Improved formulation flexibility and Improved oil control 
as it can absorb oil up to 6 times its weight without drying 
• Improved the thermal, physical, and chemical  stability of 
the drug.   
•  It should have Flexibility to develop novel product forms.  
• Microsponge systems are non-allergenic, non-irritating, 
non-mutagenic and non-toxic.   
Characteristics of the Materials Entrapped in 
Microsponges  
Majority of soluble ingredients and liquids may be 
entrapped in the microsponges. Actives that can be 
entrapped in microsponges must meet following 
requirements.  
• It should be either properly miscible in monomer or 
eligible of being made miscible by adding of small amount of 
a water immiscible solvent.  
• It should be slightly soluble or water immiscible.  
• It should be inert to monomers.  
• It should be constant in contact with polymerization 
catalyst and conditions of polymerization5.  
Potential features of microsponge drug delivery 
systems6   
The potential features are as listed:- 
1. Microsponges show acceptable stability over pH ranging 
from 1 to 11 and at high temperatures i.e up to 130°C.  
2. Microsponges exhibit good compatibility with various 
vehicles and ingredients.  
3. Microsponges have high entrapment efficiency up to 50 to 
60%.  
4. Microsponges are designated by free flowing properties.  
5. The average pore size of microsponges is small (0.25 µm) 
in a way to inhibit the penetration of bacteria, Hereby they 
do not need sterilization or addition of preservatives.  
6. Microsponges are non-mutagenic, non-allergenic, non-
irritating, and non-toxic.  
7. It can absorb oil up to 6 times their weight without drying.  
Advantages of Microsponges  
Microsponges have several advantages which are explained 
below:  
 
High surface area 
A 25 µ sphere can have a pore volume of about 1 ml/g with  
pore length of about 10 ft and can have up to 25,000 pores. 
This confer an vast surface area for high entrapment. 
Because of the entrapment and adsorption of actives upon 
the polymeric cage, the discharge of actives is sustained. This 
facilitates the formulation of skin irritants or actives with 
short time of action, which otherwise may require re-
application every few hours7.  
Simple production methodology  
The production of microsponges is comparatively simple in 
scaling up and that is why there is a higher potential for 
commercialization.  
Drugs explored in the microsponge delivery 
system8,9  
 Ketoprofen                                             Miconazole 
 Mupirocin                                               Curcumin 
 Tretinoin                                                 Itraconazole 
 Fluconazole                                             Ibuprofen 
 Hydroquinone                                         Prednisolone 
 Acyclovir Sodium                                   Paracetamol 
 Retinol                                                     Indomethacin 
 Erythromycin                                          Benzoyl Peroxide 
Release Mechanisms from Microsponges10  
Pressure Triggered System   
Microsponge system releases the entrapped material when 
pressurized; the amount released depends upon various 
characteristics of the sponge. By change the type of material 
and different process variables, the microsponge best suited 
for a given application may be optimized. When compared 
with mineral oil containing microcapsules then mineral oil 
containing microsponge showed much more softening effect. 
The period of emolliency was also much more for the 
microsponge systems.  
Temperature Triggered System   
It is believable to modulate the release of substances from 
the microsponge by penetration of temperature. The much 
viscous sunscreens were found to exhibit at peak release 
from microsponges when they exposed to high rate 
temperatures, Hereby a sunscreen would be released from a 
microsponge only onto exposure to the heat from the sun.  
pH triggered systems  
Triggering the pH-based release of the active can be 
achieved by re-producting the coating on the microsponge. 
Even though this has several applications in drug delivery, 
only a few applications are possible for cosmetic delivery.  
Solubility triggered systems  
At the present of an aqueous medium such as perspiration 
can trigger the discharge rate of active agents. Ingredients 
like antiseptics, deodorants and antiperspirants may be 
formulated in such type of systems. Release may be obtained 
based on the strength of the external medium to dissolve the 
active agent, the concentration gradient or the capacity to 
swell the microsponge network.   
Safety of microsponges  
Many polymers used in the formulation are inert and the 
incapability of microsponges to pass through the stratum 
corneum increases their safety. Furthermore, it reduces the 
irritation of various actives, and thereby demonstrates its 
harmlessness.  
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Advantages of Microsponges over other 
Formulations11  
Advantages over conventional formulations  
Conventional formulations of topical drugs are studied to 
work on the outer layers of the skin. Such type of products 
release their active agents onto application, originate a 
highly concentrated layer of active ingredient that is rapidly 
absorbed. When compared to the conventional system, 
microsponge system can prevent excessive accumulation of 
ingredients within the epidermis and the dermis. Potentially, 
the Microsponge drug delivery system can decrease 
significantly the disturbance of effective drugs without 
reducing their efficacy.   
Advantages over microencapsulation and liposomes  
The Microsponge drug delivery system has advantages over 
other technologies like microencapsulation and liposomes. 
Microcapsules cannot commonly control the release rate of 
active ingredients. Once the wall is ruptured the actives 
contained within microcapsules will be released. Liposomes 
undergo from limited chemical stability, lower payload, 
difficult formulation and microbial instability. Meanwhile, 
microsponge system in contrast to the above systems has 
various merits such as:  
 It has stability over the pH range of 1 to 11 and 
temperature up to 130°C.  
 It is compatible with most vehicles and ingredients.  
 It has the property of self-sterilizing as their average 
pore size is 0.25 µm where bacteria cannot penetrate.  
 It has higher payload and is still free flowing.  
 It has advantage of cost effectiveness over the other 
formulations.  
Advantages over ointments  
Ointments are often aesthetically unappealing, greasy and 
sticky that often results in lack of patient compliance. These 
vehicles have high concentrations of active agents for 
effective therapy therefore it has low capacity of delivering 
the active drug. As the result, into irritation and allergic 
reactions in valuable users. Other demerits of topical 
formulations are uncontrolled evaporation of active agents, 
unpleasant odour and potential incompatibility of drugs 
with vehicles12.  
Preparation of Microsponges  
Drug loading in microsponges can take place in two ways, by 
one-step or two-step process; based on physicochemical 
properties of drug to be loaded. If the drug is typically an 
inert non-polar material, it will create the porous structure 
which is called as porogen. Porogen drug, which neither 
prevent the polymerization nor get activated by it and stable 
to free radicals, that is entrapped with one-step process13.  
  
 
  
 
 
 
 
 
Liquid-liquid suspension polymerization                         Quasi emulsion solvent diffusion 
                         
 
 
                                     Based on physico-chemical properties of drug to be loaded   
Fig. 1 Methods of preparation of microsponges13 
 
Liquid-Liquid Suspension Polymerization  
Microsponges are easily prepared by liquid-liquid 
suspension polymerization method. Polymerization of 
styrene or methyl methacrylate is carry out in round bottom 
flask.  In their preparation, monomers are firstly dissolved 
along with non-polar active agents in appropriate solvent 
solution of monomer and then dispersed in the aqueous 
phase, which consists of additives like surfactant, and 
suspending agents, they are help in the formation of 
suspension. Once suspension with discrete droplets of the 
desired size is established, polymerization is achieved by 
activating monomers either by catalysis or by increased 
temperature as well as irradiation. The various steps in 
preparation of microsponges are summarized as:  
 
 
Fig. 2 Preparation of microsponges by liquid-liquid 
suspension polymerization method13 
                  Drug loading in microsponge 
One step 
process 
Two-step 
process 
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 Polymerization leads to the formation of ladders as a 
result of cross-linking between chain monomers.  
 Folding of monomer ladder lead to the formation of 
spherical particles and their agglomeration resulted in 
formation of bunches of microspheres.  
 Binding of these bunches formed microsponge.  
 After polymerization the liquid is diffused out leaving 
microsponges. Though a convenient method, major 
disadvantage of this process is probable entrapment of 
unreacted monomeric residues. 
Quasi-Emulsion Solvent Diffusion  
When the drug is sensitive to the polymerization situations, 
two-step process is used for preparation of microsponges. 
Microsponges are prepared by a quasi-emulsion solvent 
diffusion method by using the different polymer quantities. 
In the emulsion solvent diffusion the relation between the 
drug and the good solvent is stronger than that of the 
suitable solvent and the poor solvent. The drug is dissolved 
in the good solvent, and the solution is dispersed into the 
poor solvent, producing emulsion (quasi) droplets, even 
though the pure solvents are miscible. The suitable solvent 
diffuses gradually out of the emulsion droplets in the 
surrounding cheap solvent phase, and the poor solvent 
expand into the droplets by which the drug crystallizes 
within the droplets. This is a two-step process where into the 
polymer along with the active agents, plasticizer and 
diffusible substance i.e Porogen is poured into an outer 
aqueous phase, which bassically consists of a stabilizer 
namely polyvinyl alcohol. After emulsification, the system is 
continuously stirred for 2 hours and maintained at a high 
temperature if required. Diffusion of the porogen within the 
outer medium results in a large porous microparticle called 
'Microsponge'. Then the mixture is filtered and separate the 
microsponges. The product is washed and dried in vacuum 
oven at 50°C for 24 hours.  
 
 
Fig. 3 Preparation of microsponges by quasi-emulsion solvent diffusion method12,13 
Formulation Considerations  
Active ingredients entrapped in microsponge delivery 
system then it can be incorporated into many products such 
as that soaps, creams, lotions and powders. Meanwhile 
formulating the vehicle, few opinions are taken into account 
in order to obtain required product characteristics. These 
are as follow below:  
1. The solubility of actives in the vehicle must be limited. 
Otherwise the vehicle will deplete the microsponges before 
the application.  
2. To avert cosmetic problems, not >10 to 12% w/w 
microsponges must be incorporated into the vehicle.  
3. Polymer design and payload of the microsponges for the 
active must be optimized for required release rate for a 
given time period. There remains equilibrium between 
microsponge and vehicle and microsponge releases drug in 
response to the depletion of drug concentration in the 
vehicle. The concentration of the drug in the vehicle is 
depleted by absorption of the drug into the outer layer of the 
skin. Hereby continuous and steady release of active agents 
into the skin is efficient with this system.  
Sustained release microsponges can also be developed. 
Several factors that are to be            believed during 
development of such formulations comprise physical and 
chemical properties of entrapped active ingredients14.  
Effect of Formulation Variables on Physical 
Properties of Microsponges15   
Effect of composition of internal and external phases  
It is found that particle sizes of microsponges were directly 
proportional to the apparent viscosity of dispersed phase. If 
the difference between apparent viscosity of dispersed and 
continuous phase is high, the mean particle size of the 
microsponge is large. When the dispersed phase with higher 
viscosity is poured into the continuous phase (external 
phase), due to the higher viscosity of the internal phase, the 
globules of the formed emulsion can hardly be divided into 
smaller particles and bigger droplets are found resulting in 
an increase in mean particle size. Good microsponges can be 
produced only when 3 to 5 ml of internal phase is used. 
When increased the amount of internal phase from 5 to 15 
ml, the production yield and drug content of the 
microsponges is found to be reduced. This happens because 
of the lower concentration of the drug in the higher volume 
of internal phase.   
Effect of drug to polymer ratio  
When the amount of polymer is kept constant however the 
ratio of drug to polymer is modified, the drug loading 
capacity is not much affected by drug to polymer ratio 
however production yield can be extremely altered from 
minimum ratio to a maximum one. Second parameter which 
is affected from drug: polymer ratio change is particle size. It 
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has been examined that when drug amount is increased so 
that particle size of the microsponges is also enhanced.  
Effect of Process Variables on Physical Properties 
of Microsponges15,16 
Effect of stirring rate  
As the stirring rate is increased, the size of obtained 
microsponge is smaller. Increase in the stirring rate 
decreases the production yield but the drug content gets 
increased which indicates that the drug loss is decreased as 
the stirring rate is increased. This is due to the turbulence 
created within the external phase due to which polymer gets 
adhered to the paddle and production yield gets decreased.  
Physical Characterization of Microsponges17,18,19,20  
Particle Size Determination   
Free-flowing powders with fine aesthetic properties are 
possible to achieve by controlling the size of particles during 
polymerization. Particle size examination of loaded and 
unloaded microsponges can be carried out by laser light 
diffractometry or by any other suitable method. The values ( 
d 50) can be denoted for all formulations as mean size range. 
Cumulative percentage drug release from microsponges of 
different particle size is plotted against time to study the 
effect of particle size on drug release. Particles larger than 
30 μm can give gritty feeling and hence particles of sizes 
between 10 and 25 μm are privileged to use in final topical 
formulation.  
Morphology and Surface Topography of Microsponges  
At room temperature microsponges can be coated with 
gold–palladium beneath an argon atmosphere for the 
purpose of morphology and surface topography, then the 
surface morphology of the microsponges can be well read by 
scanning electron microscopy. SEM of a fractured 
microsponge particle can also be taken to exemplify its 
ultrastructure.   
Determination of Loading Efficiency and Production 
Yield   
The loading efficiency (%) of the microsponges can be 
calculated according to the following equation: 
Loading efficiency =  Actual drug content in microsponges ×100        
                                 Theoretical drug content 
The production yield of the microsponges can be determined 
by calculating accurately the initial weight of the raw 
materials and the last weight of the microsponge obtained.  
Determination of true density  
Production Yield (PY) = Practical mass of microsponges ×100                                                
                                        Theoretical mass (polymer + mass)                            
The true density of microparticles can be measured using an 
ultra-pycnometer under helium gas and is calculated from a 
mean of repeated determinations.  
Compatibility Studies 
Thin layer chromatography and Fourier Transform Infra-red 
Spectroscopy can be used to study the compatibility of drugs 
with excipients. X-ray diffraction and Differential Scanning 
Colorimetry (DSC) used to study the polymerization on 
crystallinity of the drug.  
Polymer/ Monomer Composition  
Factors such as microsponge size, drug loading, and polymer 
design regulate the drug release from microsponge. Polymer 
creation of the microsponge drug delivery system can affect 
partition coefficient of the entrapped drug between the 
vehicle and the microsponge system, Hereby it has direct 
impact on the release rate of entrapped drug.   
Release of drug from microsponge systems of different 
polymer compositions can be intended by plotting 
cumulative percent (%) drug release against time.  
Selection of monomer is dictated both by characteristics of 
active ingredient ultimately to be entrapped and by the 
vehicle into which it will be dispersed. Polymers with 
varying electrical charges or degrees of hydrophobicity or 
lipophilicity may be prepared to confer flexibility in the 
release of active agents. Several monomer combinations will 
be screened for their suitability with the drugs by studying 
their drug release profile.  
Resiliency (viscoelastic properties) 
Resiliency (viscoelastic properties) of microsponges can be 
improved to produce beadlets that are softer or stable 
according to the requirements of the final formulation. The 
rate of release gets slow down by increased cross-linking. 
However, resiliency of microsponges will be studied and 
optimized as per the requirement by considering release as a 
function of cross-linking with time. 
Applications of Microsponge Systems21,22  
Microsponges are porous, polymeric microspheres that are 
used mostly for topical delivery of drug and recently it is 
used for oral administration. It proposed the formulator a 
range of substitute to drug and cosmetic products. 
Microsponges are designed to deliver an active 
pharmaceutical ingredient efficiently at the low dose and 
also to increased stability, reduce side effects and modify the 
drug release. Various applications of microsponge systems 
are summarized in Table 1. 
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TABLE 1: Applications of microsponge systems. 
S. 
N. 
             Active agents                                   Applications 
1. Sunscreens Sunscreens are the products which prolonged efficacy and protection against 
various sun injuries and sun burns. Which occurs at high concentration on the 
skin.  
2. Anti-acne e.g. Benzoyl 
peroxide 
Benzoyl peroxide known for these products maintaining the efficacy with 
reduction in skin sensitization and irritation problems.  
3. Anti-inflammatory e.g. 
hydrocortisone 
These provides reduction in the skin inflammation and certain allergic 
responses and dermatoses with long lasting effect.  
4. Anti-fungal e.g. Fluconazole These products are well known for providing the active sustained effect of 
pharmaceutical active ingredients.  
5. Anti-dandruffs e.g. zinc 
pyrithione, selenium sulfide 
These Anti-dandruff products provide reduction in the unpleasant and foul 
odour with extended safety and efficacy, in addition to the reduction in 
irritation of scalp also.  
6. Antipruritics Extended and improved activity. 
7. Skin depigmenting agents e.g. 
hydroquinone 
They are well known for providing stabilization against the various oxidation 
reactions with improvement in aesthetic properties.  
8. Rubefacients They have long time activity with reduced irritancy greasiness and odour. 
 
Microsponge delivery systems are used to increase the 
safety, efficacy and aesthetic properties of topical, over-the 
counter ("OTC") and personal care products. Products under 
development or in the market place make use of the topical 
microsponge systems in three primary ways;  
1. As reservoirs releasing active ingredients over an 
extended period of time. 
2. As receptacles for absorbing undesirable substances that 
is excess skin oils. 
3. As closed containers holding actives away from the skin 
for superficial action.  
 (i) Topical drug delivery using microsponge 
technology23,24 
Benzoyl peroxide (BPO) is commonly used in topical 
formulations for the treatment of acne and athletes foots. 
Skin irritation is a common side effect, and it has been shown 
that controlled release of BPO from a drug delivery system to 
the skin could reduce the side effect while reducing 
percutaneous absorption. Benzoyl peroxide microparticles 
were prepared by using quasi emulsion solvent diffusion 
method then the addition of an internal phase (benzoyl 
peroxide, ethyl cellulose and dichloromethane) into a 
aqueous phase (polyvinyl alcohol).  
Disorders of hyperpigmentation such as that melasma and 
post-inflammatory hyperpigmentation are common, 
especially among people with darker skin types. 
Hydroquinone bleaching creams are believed the gold 
standard for treating hyperpigmentation. Recently, a new 
formulation that is 4% Hydroquinone with 0.15% retinol 
entrapped in microsponge reservoir was evolved for the 
treatment of melasma and post-inflammatory 
hyperpigmentation. Microsponges were used to release HQ 
gradually to prolonged exposure to treatment and to 
minimize skin irritation.  
Microsponges containing mupirocin were prepared by an 
quasi-emulsion solvent diffusion method. The optimized 
microsponge were incorporated into an emulgel base. Drug 
release through cellulose dialysis membrane showed 
diffusion controlled release pattern an drug deposition 
studies using rat abdominal skin exhibited significant 
retention of active in skin from microsponge based 
formulations by 24 hour. The optimized formulation were 
stable and non-irritant to the skin as demonstrated by Draize 
patch test. Microsponges-based emulgel formulation short 
prolonged efficacy in mouse surgical wound model infected 
with staphylococcus aureus. Formulation of mupirocin was 
best fitted in topical emulgel formulations and exhibit 
increased conception in the skin signalling better potential of 
the delivery system for treatment of primary and secondary 
skin infections such as impetigo, eczema, and atopic 
dermatitis.   
(ii) In oral drug delivery using microsponge technology  
A microsponge system offers several advantages for oral 
drug delivery such as:   
1. Preserve the active ingredients within a protected 
environment and proposed oral controlled delivery to the 
lower part of the gastrointestinal tract.  
2. Microsponge systems improve the solubility of poorly 
soluble drugs by entrapping these drugs in their porous 
structure.  
3. As the porous structure of the microsponge is very small in 
size, the drugs entrapped will be reduced to microscopic 
particles with higher surface area, and consequently 
improved rate of solubilization.  
4. Maximize the amount of drugs to be absorbed, as the time 
it takes the microsponge system to pass through the 
intestine is considerably increased.  
In oral drug delivery the microsponge system increase the 
rate of solubilization of poorly water soluble drugs by 
entrapping them in the microsponge system’s pores. As these 
pores are very small the drug is in effect decreased to 
microscopic particles and the considerable increase in the 
surface area hereby greatly increase the rate of 
solubilization.  
(iii) In Bone tissue engineering using microsponge 
technology 
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3D biodegradable porous scaffold perform a very vital role in 
articular cartilage tissue engineering. The hybrid structure of 
3D scaffolds was evolved the merits of natural type I collagen 
and synthetic PLGA knitted mesh. The mechanically strong 
PLGA mesh served as a skeleton meanwhile the collagen 
microsponges facilitated cell seeding and tissue formation. 
The scaffolds were divided into three sets:   
(1) THIN: In this the collagen microsponge formed in 
interstices of PLGA mesh.    
(2) SEMI: In this collagen microsponge formed on one side of 
PLGA mesh.    
(3) SANDWICH: In this scaffold collagen sponge formed on 
both sides of PLGA mesh. Bovine chondrocytes were cultured 
in these scaffolds and transplanted subcutaneously into nude 
mice for two to eight weeks.  
All three groups of transplants exhibit natural chondrocyte 
morphology, uniform cell distribution and abundant 
cartilaginous ECM deposition. Output of GAGs per DNA and 
the statement of type II collagen and aggrecan mRNA were 
too higher in the SEMI and SANDWICH groups than in the 
THIN group. When collate to native articular cartilage, the 
mechanical capacity of the engineered cartilage attain 54.8%, 
49.3% in Young's modulus and 68.8%, 62.7% in stiffness, 
systematically, in SEMI and SANDWICH. These scaffolds 
could be employed for the tissue engineering of articular 
cartilage with adjustable fattening. The design of the hybrid 
structures confer a strategy for the preparation of 3D porous 
scaffolds.  
A novel 3D porous scaffold has been evolved for bone tissue 
engineering by hybridizing synthetic poly (DL-lactic-co-
glycolic acid), inorganic apatite and naturally derived 
collagen. Firstly, a porous PLGA sponge was prepared after 
that collagen microsponges were formed in the pores of the 
PLGA sponge. Finally, apatite particulates were deposits on 
the surfaces of the collagen microsponges in the pores of 
PLGA sponge. The PLGA-collagen sponge served as a 
template for apatite deposition, and the deposition was well 
seen by optional immersion of PLGA–collagen sponge in 
calcium chloride and disodium hydrogen phosphate aqueous 
solutions and centrifugation. The deposited particulates 
were little and insignificant after one cycle of optional 
immersion. Their number and size increased with the 
number of alternate immersion cycles.  
 (iv) In cardiovascular engineering using microsponge 
technology   
A biodegradable material with autologous cell seeding 
requires a complicated and invasive procedure that carries 
the risk of infection. To avoid these issues, a biodegradable 
graft material inclusive collagen microsponges that would 
allow the regeneration of autologous vessel tissue has 
developed. The capability of this material to accelerate in situ 
cellularization with autologous endothelial and smooth 
muscle cells was analysed with and without pre-
cellularization.   
Poly (lactic-co-glycolic acid) as a biodegradable scaffold was 
adjunct with collagen microsponge to form a vascular patch 
material. These poly (lactic-co-glycolic acid) collagen patches 
with or without n = 10 autologous containers cellularization 
were used to patch the canine pulmonary artery trunk. 
Histologic and biochemical assessments were performed 2 
and 6 months after the implantation. There was no thrombus 
formation in either group, and the poly (lactic-co-glycolic 
acid) scaffold was almost completely absorbed in both 
groups.  
Histologic results showed the formation of an endothelial cell 
monolayer, a parallel alignment of smooth muscle cells, and 
reconstructed vessel wall with elastin and collagen fibres. 
The cellular and extracellular components in the patch had 
increased to levels similar to those in native tissue at 6 
months. This patch demonstrate statement as a 
bioengineered material for promoting in situ cellularization 
and the regeneration of autologous tissue in cardiovascular 
surgery.  
(v) In reconstruction of vascular wall using microsponge 
technology  
The tissue-engineered patch was fabricated by compounding 
a collagen-microsponge with a biodegradable polymeric 
scaffold composed of polyglycolic acid knitted mesh, 
reinforced on the outside with woven polylactic acid. Tissue-
engineered patches without pre-cellularization were grafted 
into the porcine descending aorta n = 5, the porcine 
pulmonary arterial trunk n = 8, or the canine right 
ventricular outflow tract (as the large graft model; n = 4). 
Histologic and biochemical assessments were performed 1, 
2, and 6 months after the implantation. There was no 
thrombus formation in any animal. Two months after 
grafting, all the grafts exhibit appropriate in situ 
cellularization by hematoxylin/eosin and immunostaining. 
The quantification of the cell population by polymerase chain 
reaction demonstrate a large number of endothelial and 
smooth muscle cells 2 months after implantation. In the huge 
graft model, the architecture of the patch was identical to 
that of native tissue 6 months after implantation and this 
patch can be employed as a surgical material for the 
repairing of the cardiovascular system.  
The resulting advantages comprise extended efficacy, 
decreased skin irritation, cosmetic elegance, formulation 
flexibility and improved product stability.  
Marketed Formulation Using the MDS25,26 
Marketed formulation using the microsponge drug delivery 
system comprise Ethical Dermatological products (APS 
defined ethical dermatological products as prescriptional 
and non-prescriptional drugs that are encouraged primarily 
through the medical profession for the purpose of prevention 
and treatment of skin problems or diseases). Several ethical 
dermatology products approved by US FDA as over the 
counter (OTC) and personal care products are sold in the 
United States. Results from several human clinical studies 
affirmed that the technology proposed the potential to 
decrease the drug side effects, maintains the therapeutic 
efficacy and potentially enhanced the patient compliance 
with the treatment regimen.  Ethical dermatological products 
that have been developed or are under development include,   
Tretinoin Acne Medication   
In February 1997, the food and drug administration 
approved the first ethical pharmaceutical product based on 
patented microsponge technology; Retin-A-Micro(TM), 
which has been licensed to Ortho-McNeil Pharmaceutical 
Corporation. This product was launched in March 1997. 
Although, skin irritation among sensitive individuals can 
extent patient compliance with the prescribed therapy. The 
company consider its patented influence to decrease the 
potentially irritating side effects of tretinoin. Ortho 
Dermatological began the marketing of this product in March 
1997.   
5-Fluorouracil (5-FU)   
5-FU is an effective chemotherapeutic agent for treating 
actinic keratosis, a pre-cancerous, hardened skin condition 
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caused by excessive exposure to sunlight. Although, patient 
compliance with the treatment regimen is cheap, due to 
considerable adverse side effects. Microsponge-increased 
topical formulation, that potentially purpose a less irritating 
solution for treating actinic keratosis, is sold under the brand 
name of Carac.   
Tretinoin Photo-damage Treatment  
Product containing microsponge system for the treatment of 
photo-damage, which contributes to the premature aging of 
skin and in skin cancer, is also developed.   
Cosmeceutical Product Retinol  
Retinol is a highly pure form of vitamin A which has exhibit a 
remarkable capability for maintaining the skin's youthful 
appearance. Although, it has been achievable only on a 
moderate basis because it becomes unstable when mixed 
with other active ingredients. Stabilized retinol in a 
formulation which is cosmetically elegant and which has a 
low potential for skin irritation is successfully developed and 
marketed.  
Personal Care and OTC Products  
Microsponge drug delivery system is ideal for skin and 
personal care products. They can retain various times their 
weight in liquids, absorb large amounts of excess skin oil and 
respond to a variety of release stimuli. Hereby, retaining an 
aesthetic feel on the skin's surface. This technology is 
presently employed in nearly number of products sold by 
major cosmetic and toiletry companies worldwide. Among 
these products skin makeup, powders, cleansers, 
conditioners, oil control lotions, moisturizers, deodorants, 
razors, lipstick, and eye shadows are introduced. Which 
proposed various advantages, including improved physical 
and chemical stability, controlled release of the active 
ingredients, greater available concentrations, reduced skin 
irritation and sensitization, and unique tactile qualities27. 
Several marketed products utilizing microsponge drug 
delivery system summarizes in Table 2. 
  
TABLE 2: Marketed products using microsponge drug delivery system 
    Product                                   Advantages     Manufacturer 
Retin-A-Micro   Around 0.1% and 0.04% tretinoin entrapped in microsponge drug 
delivery for topical treatment of acne vulgaris. This formulation uses 
patented methyl methacrylate/ glycol dimethacrylate cross-polymer 
porous microspheres (MICROSPONGE® System) to enable inclusion of 
the actives, tretinoin, in an aqueous gel. 
Ortho-McNeil 
Pharmaceutical, Inc.   
Carac Cream, 0.5%   It consist of fluorouracil up-to 0.5 %, with 0.35% being inclusive into a 
patented microsponge that is composed of methyl methacrylate or glycol 
dimethacrylate cross-polymer and dimethicone. It is a topical prescription 
product for the treatment of actinic keratoses (AK) and used once-a-day, a 
common pre-cancerous skin condition caused by over-exposure to the 
sun. 
Dermik 
Laboratories, Inc. 
Retinol cream   The retinol molecule is kept in the microsponge system to protect the 
potency of the vitamin A. This helps to enhance retinol dosage meanwhile 
decreasing the possibility of irritation. Retinol is a topical vitamin A 
derivative which helps to  maintain the healthy skin, hair and mucous 
membranes. 
Biomedic, Inc. 
Biomedic, Inc. The Microsponge ® system uses the microscopic reservoirs that trap HQ 
and retinol. This confer the skin with continuous exposure to 
hydroquinone and retinol over time, which may reduced skin irritation.    
SkinMedica Inc   
Line Eliminator 
Dual Retinol Facial 
Treatment 
Lightweight cream with a retinol in microsponge drug delivery system, it 
delivers both immediate and time released of drug and having wrinkle-
fighting action. 
Avon 
Retinol 15 
Nightcream 
When we use Retinol 15 continuously in night will results in the visible 
diminishment of fine lines and wrinkles, a observable improvement in the 
skin discolorations due to aging and enhanced skin smoothness. 
Sothys  
   
EpiQuin Micro This confer the skin with continuous exposure to hydroquinone and 
retinol over time, which may reduced skin irritation. 
Skin medica inc.  
Sports cream RS 
and XS 
Topical analgesic-anti-inflammatory and counterirritant actives used for 
the management of musculoskeletal conditions in a Microsponge® 
Delivery System.  
Embil 
pharmaceutical co. 
Ltd. 
 
APS developed microsphere precursors to the microsponge 
for use as a testing standard for gauging the purity of 
municipal drinking water. Marketed nationwide, these 
microspheres are suspended in pure water to form an 
accurate, stable, reproducible turbidity standard for the 
graduation of turbidimeters used to examine water purity. 
The technology can have much broader applications than 
testing the turbidity of water and can even be used for the 
calibration of spectrophotometers and colorimeters.  
 
CONCLUSION  
Microsponge Delivery System can entrap wide range of 
actives and then release them onto the skin at a time and in 
response to trigger. It is exclusive technology for the 
controlled release of topical agents and it consists of 
microporous beads loaded with active ingredients. Thus, use 
for oral as well as biopharmaceutical drug delivery also. MDS 
can release its active agent on a time mode and in response 
to other stimuli also. Hereby, microsponge has got a lot of 
potential and is a very emerging field which is needed to be 
explored.  
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